Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8 - Infast Group PLC

14 Apr 2005 09:40

Societe Generale Asset Mngmt UK Ld14 April 2005 Date of Disclosure 14/04/05 DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) and 8.3 OF THE CITY CODE ON TAKEOVERS AND MERGERS Date of dealing 13/04/05 Dealing in INFAST GROUP PLC (name of company) 1) Class of securities (eg ordinary shares) ORD 2) Amount bought Amount sold Price per unit 75000 0.23 3) Resultant total of the same class owned or controlled (and percentage of class) 7,135,000 (6.24%) 4) Party making disclosure SOCIETE GENERALE ASSET MANAGEMENT UK LIMITED 5) EITHER (a) Name of purchaser/vendor (Note 1) OR (b) if dealing for discretionary client(s), name of fund management organisation SOCIETE GENERALE ASSET MANAGEMENT UK LIMITED 6) Reason for disclosure (Note 2) (a) associate of (i) offeror (Note 3) NO (ii) offeree company NO Specify which category or categories of associate (1-8 overleaf) If category (8), explain (b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more of the class of relevant securities dealt in) YES Signed, for and on behalf of the party named in (4) above N/A (Also print name of signatory) HANNAH MUNDAY Telephone and extension number 020 7090 2508 Note 1. Specify owner, not nominee or vehicle company. If relevant, also identify controller of owner, eg where an owner normally acts on instructions of a controller Note 2. Disclosure might be made for more than one reason; if so, state all reasons. Note 3. Specify which offeror if there is more than one. Note 4. When an arrangement exists with any offeror, with the offeree company or which an associate of any offeror or of the offeree company in relation to relevant securities, details of such arrangement must be disclosed, as required by Note 6 on Rule 8 Note 5. It may be necessary, particularly when disclosing derivative transactions, to append a sheet to this disclosure form so that relevant information can be given. Note 6. In the case of an average price bargain, each underlying trade should be disclosed. Note 7. The resultant total percentage holding of the class of relevant security is to be calculated by reference to the percentage held and in issue outside treasury. For full details of disclosure requirements, see Rule 8 of the Code. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring Section, Tel. No:020 7638 0129. Email: monitoring@disclosure.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Oct 20233:20 pmRNSHolding(s) in Company
3rd Oct 20232:25 pmRNSForm 8.3 -INSTEM PLC
3rd Oct 20232:10 pmPRNForm 8.3 - Instem Plc
3rd Oct 202312:31 pmRNSForm 8.3 - Instem PLC
3rd Oct 202312:20 pmRNSForm 8.3 - Instem PLC amendment
3rd Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
3rd Oct 202310:04 amRNSForm 8.3 - Instem Plc
2nd Oct 20232:53 pmRNSForm 8.3 - INSTEM PLC
2nd Oct 20232:37 pmGNWForm 8.3 - Instem Plc
2nd Oct 20231:50 pmRNSForm 8.3 - Instem PLC
2nd Oct 202312:00 pmRNSForm 8.5 (EPT/RI) - Instem plc
2nd Oct 20239:02 amRNSForm 8.5 (EPT/RI)
29th Sep 20232:59 pmGNWForm 8.3 - Instem PLC
29th Sep 20232:08 pmPRNForm 8.3 - Instem Plc
29th Sep 20232:04 pmGNWForm 8.3 - [Instem plc - 28 09 2023] - (CGAML)
29th Sep 202310:18 amRNSForm 8.5 (EPT/RI)
27th Sep 20235:28 pmRNSHolding(s) in Company
27th Sep 20233:27 pmRNSForm 8.3 - Instem PLC
27th Sep 20231:20 pmPRNForm 8.3 - Instem Plc
27th Sep 202310:03 amRNSForm 8.5 (EPT/RI)
27th Sep 20239:50 amRNSForm 8.3 - Instem Plc
26th Sep 202312:03 pmRNSForm 8.5 (EPT/RI)
25th Sep 20234:24 pmRNSPublication of Scheme Document
25th Sep 20233:27 pmRNSForm 8.3 - Instem PLC
25th Sep 20239:29 amRNSForm 8.3 - Instem Plc
25th Sep 20239:24 amRNSForm 8.5 (EPT/RI)
22nd Sep 202311:52 amRNSForm 8.5 (EPT/RI)
21st Sep 20231:07 pmRNSForm 8.3 - Instem plc
21st Sep 202311:51 amRNSForm 8.5 (EPT/RI)
20th Sep 202310:07 amRNSForm 8.5 (EPT/RI)
20th Sep 20239:00 amRNSForm 8.3 - Instem Plc
19th Sep 20237:00 amRNSGrant of PDMR Options
18th Sep 20233:27 pmRNSForm 8.3 - Instem PLC
18th Sep 202310:09 amRNSForm 8.5 (EPT/RI)
15th Sep 20232:11 pmPRNForm 8.3 - Instem Plc
15th Sep 202311:15 amRNSHalf-year Report
15th Sep 202310:52 amRNSForm 8.3 - Instem plc
15th Sep 202310:38 amRNSForm 8.5 (EPT/RI)
15th Sep 20239:40 amRNSForm 8.3 - Instem Plc
14th Sep 20231:31 pmGNWForm 8.3 - Instem PLC
14th Sep 202311:45 amRNSForm 8.5 (EPT/RI)
14th Sep 202310:12 amRNSForm 8.3 - Instem plc
13th Sep 20232:30 pmRNSForm 8.3 - Instem plc
13th Sep 20231:01 pmPRNForm 8.3 - Instem Plc
13th Sep 20239:04 amRNSForm 8.3 - Instem plc
12th Sep 20239:41 amRNSForm 8.5 (EPT/RI)
11th Sep 20234:30 pmRNSForm 8.3 - Instem plc
11th Sep 20239:32 amRNSForm 8.3 - Instem Plc
8th Sep 20233:00 pmBUSForm 8.3 - INS LN
8th Sep 20232:50 pmRNSForm 8.3 - Instem plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.